jocelynhudson

15 POSTS 0 COMMENTS

Patients with atrial fibrillation who are frail or have cognitive impairment...

Malini Madhavan (Department of Cardiology, Mayo Clinic, Rochester, Minnesota, USA) and others reported the results of a study in American Heart Journal that found...

More research needed to justify continued use of wearable cardioverter defibrillator...

Ahmad Masri (Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA) and others report in JACC: Clinical Electrophysiology that a systematic...

Use of a radiation safety time out reduces radiation exposure during...

A study carried out at the New York University Langone Health Electrophysiology Lab (New York, USA) showed significantly reduced radiation exposure levels after implementing...

New financing to commercialise Globe system for treatment of atrial fibrillation

In a new financing round, Kardium has raised an undisclosed amount to fund commercial activities in Europe and Canada, and for clinical testing of the Globe...

First patient enrolled in ICE-AFIB clinical trial

A press release reports that the first patient has been enrolled in the ICE-AFIB clinical trial (AtriCure). Following Investigational Device Exemption (IDE) approval by...

Top 10 takeaways – the need to increase focus and awareness...

A new report from Biosense Webster sets out the scale and impact of atrial fibrillation (AF) across Europe and calls for greater awareness and...

New AHA treatment guidelines for use of blood thinners with atrial...

A newer type of blood-thinning medications, non-vitamin K oral anticoagulants (NOACs), is now recommended as the preferred alternative to warfarin for reducing the risk...

Cardiac Rhythm News Issue 43 — January 2019

Highlights: "No serious adverse outcomes" with ICD shocks in young athletes playing sport Computerised-decision support has the potential to be a "powerful tool" for...

Medtronic to acquire EPIX Therapeutics

Medtronic has announced that it has entered into a definitive agreement to acquire EPIX Therapeutics. When completed, the EPIX acquisition will expand the Medtronic...

The link between atrial fibrillation and obstructive sleep apnoea

Obstructive sleep apnoea and atrial fibrillation (AF) have presented many challenges, including identifying which patients need to be assessed for obstructive sleep apnoea and...

Prevent POAF by simultaneous monitoring of autonomic tone and ectopic activity

Simultaneous monitoring of autonomic tone and ectopic activity could be used to prevent the occurrence of postoperative atrial fibrillation (POAF). Flavia Ravelli (Department of...

First AI-driven wearable heart monitor that prevents heart disease and stroke...

Cambridge Heartwear is announcing the launch of their company and release of their Heartsense monitor in 2019. In the US, strokes are among the...

Bardy Diagnostics achieves milestone of 40,000 patients monitored by the Carnation...

It has been announced that Bardy Diagnostics has monitored over 40,000 patients driven by rapid adoption of the Carnation Ambulatory Monitor (CAM), the world's...

FDA approval granted for VASCADE MVP system

Premarket Approval (PMA) from the US Food and Drug Administration (FDA) has been granted for the VASCADE MVP Venous Vascular Closure System (Cardiva Medical)....

First patient treated in TERMINATE AF clinical trial

The first patient has been treated in the TERMINATE AF trial (Medtronic). This is a multi-centre study evaluating two surgical ablation devices—the Cardioblate irrigated...